KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)R&D In ProcessReceivables - NetShares IssuedShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt issuances
Ratios

AbbVie (ABBV) Other Gross PP&E Adjustments (2016 - 2025)

AbbVie has reported Other Gross PP&E Adjustments over the past 14 years, most recently at $12.8 billion for Q4 2025.

  • Quarterly Other Gross PP&E Adjustments rose 4.57% to $12.8 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $12.8 billion through Dec 2025, up 4.57% year-over-year, with the annual reading at $12.8 billion for FY2025, 4.57% up from the prior year.
  • Other Gross PP&E Adjustments was $12.8 billion for Q4 2025 at AbbVie, up from $12.2 billion in the prior quarter.
  • Over five years, Other Gross PP&E Adjustments peaked at $12.8 billion in Q4 2025 and troughed at $10.0 billion in Q4 2021.
  • The 5-year median for Other Gross PP&E Adjustments is $11.0 billion (2022), against an average of $11.4 billion.
  • Year-over-year, Other Gross PP&E Adjustments dropped 0.64% in 2023 and then increased 12.33% in 2024.
  • A 5-year view of Other Gross PP&E Adjustments shows it stood at $10.0 billion in 2021, then increased by 9.99% to $11.0 billion in 2022, then dropped by 0.64% to $10.9 billion in 2023, then rose by 12.33% to $12.2 billion in 2024, then grew by 4.57% to $12.8 billion in 2025.
  • Per Business Quant, the three most recent readings for ABBV's Other Gross PP&E Adjustments are $12.8 billion (Q4 2025), $12.2 billion (Q4 2024), and $10.9 billion (Q4 2023).